
As many patients already know, urinary tract infections (UTIs) can recur despite the use of antibiotics. So, it’s welcome news that the U.S. Food and Drug Administration on Wednesday approved Pivya (pivmecillinam) to fight bacterial UTIs. “UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” Dr.… read on > read on >